Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Would put share price at $1.38 ….
Which is very realistic at some point in June/July.
And good chance of FDA approval ….
Within less than 30 days afterwards.
Whoever sold yesterday is going to regret it ….
They sold at the 104 week low.
Not smart.
So go back and edit your post as bullish
It appears a large shareholder is dumping all their shares.
They’ll regret it though.
The pet division would sell for way higher than $500,000 or a million ….
I’m guessing it would sell for at least $300 million bare minimum, which still puts share price at $0.75 or so on that buyout alone.
Yeah, I don’t know why so many are worried about 11 million shares ….
That is absolutely nothing compared to how other companies dilute.
This gives Korenko and Vivos an additional $800,000 or so, that they add to the stash, and they’re primed and ready for the next year at least.
They may do the next round at $1.00 for all we know (after IDE), or higher than $1.00, and would only need to dilute 3 million shares to get $3 million or so at that time.
They’re doing everything right so far along the way. And being very cautious too.
People need to stop complaining.
The collective narrative is that the near 106 million shares are still for the Reg S ….
And they couldn’t say that yet in the filing, so they had to word it the way they did. And yeah, the Dryworld Global thing kind of gives it away like you mentioned.
And they issued exactly 105,940,429 shares on April 12 at $0.01 for cash and services according to the filing. Talk about an odd number.
And who would even pay them $0.01 at this point (or early April for that matter) for over 105 million shares? And why for that “exact” number of 105,940,429 shares? Looks like a “conversion” to me, being a weird number of shares like that. Based on all of that, logic seems to be it’s a conversion, i.e. the Reg S.
Time will tell, so we’ll just have to see how it plays out.
Others who are providing capital are getting shares for $0.005 range. Not for $0.01. The convertible debt is getting a conversion rate of $0.005. Who the hell is going to give them over a million dollars at $0.01 (105+ million shares), when the conversion rate for debt has been at $0.005.
Good thing it’s only 11 million shares ….
11 million * $0.08 (Reg A price)
= over $800,000 they should get from it after paying the commission fees, etc.
This is the perfect 30 year investment ….
Just buy a slew of shares at rock bottom price, and wait for Brian’s son to deliver us future gains down the road, and we can then celebrate our elder years at that time during autonomous driving in our new $1 million vehicle then.
I’m looking forward to it.
Only 10,950 days away.
The market cap is so low at rock bottom ….
That it still went green today.
Just move it back to a shell play, and let it correct itself to a historical average of $3 million market cap for a shell play.
Market cap is still only $500,000 here. That is a big nothing burger, and theoretically any shell play is worth at least a couple million dollars in market cap historically, and this one was cleaned up and only at 17 million O/S.
Some of those 11 million shares of dilution are being sold today.
Whoever sold that is a real idiot.
Predictions for 2024 / 2025 ….
What will the share price YTD high be for 2024?
What will the share price YTD high be for 2025?
What will the share price YTD high be for 2026?
It’s definitely not toxic dilution ….
It’s the good kind of dilution, good for us. It gets the technology to market, and overseas too, etc.
I’d say all of that is worth the dilution of 11 million shares ….
All of that stuff you mentioned is good for us shareholders.
Even if O/S gets up to 500 million ….
$2.5 billion buyout / 500 million shares
= $5.00 per share
$2.5 billion buyout at that time
1:50 pm (eastern time)
Why would big pharma shut it down? ….
When they could instead buy out the technology for $2 or $3 billion.
Korenko would sell it at a fair price to them, as he is not getting younger.
How high do you think PPS will be? ….
Soon after IDE approval (if FDA does approve it) ???
Message from the other RDGL board ….
$RDGL I’m thinking $0.44 day before submission. Up to $0.77 during the 30 days (or less). $2.22 after approval... From there, who knows!!!
If even just 1% of them became buyers ….
That is 5,000 buyers from 500,000 of his followers.
5,000 buyers coming in would move this stock up near dollar land, and possibly $1.00+ within days or a couple short weeks.
That is huge ….
Zack Morris has over 500,000 subscribers.
Over 500,000 additional investors just found out about RDGL.
Prediction: Do we close above $0.20 today?
If approved to treat all solid tumors ….
This is eventually a $100 billion technology.
Big pharmaceutical would pay at least $10 billion if not $20 billion buyout to capitalize on that opportunity.
Imagine getting like $25.00 or more for each of our shares from a buyout.
((((((( ATTENTION RDGL HOLDERS ))))))) ….
“Know What you Own”
Backed by Mayo Clinic.
This is NOT your ordinary crap “OTC Play”, or one that only runs up on hype and then you “sell on the news” when the PR comes out.
This is an “investment” that you hold on to.
The FDA has been working directly with Vivos (RadioGel) and Mayo Clinic, and the FDA is putting in their precious time to “see it through”. The FDA already knows ahead of time if it will ultimately be approved or not, and if they knew it wasn’t getting approved, they wouldn’t be working this closely with Vivos and Mayo Clinic.
It’s a process and needs to be thorough. We’re dealing with cancer here, and not some simple pharmaceutical pill that potentially gets approved by helping reduce inflammation or headache pain by 5%. The market is already flooded with crap pills that barely help, if at all, on common symptoms that a large chunk of humans get.
This is cancer.
This is a new tool to fight cancer.
Backed by the world’s #1 medical clinic and hospital, Mayo Clinic.
Think about that for a moment.
Think about what your tickets (shares) will be worth when FDA approved.
Think about how many international countries and patents that Dr. Korenko has already lined up and agreed contractually with.
This technology is “in demand”
Worldwide.
World freaking wide.
This isn’t some bull crap nuts and bolts machinery system that gets hyped up in the OTC on a pump, when the machine doesn’t exist.
There’s no way you should ever want to trade (sell) this stock like it’s one of those.
This technology is also backed by celebrities such as Nancy Kerrigan and the Dos Equis guy.
And a lot more.
This is a multi billion dollar technology.
“in Demand” worldwide.
Don’t be stupid.
This is a stock that you stay patient and don’t “over-think” it.
“KNOW WHAT YOU OWN”
Period
Yeah, it appears Carnes didn’t benefit ….
at all financially from APSI / Tradition.
It seems logical it would be in his best interest now to look for another company to come in to APSI, via reverse merger or acquisition.
My guess on that is end of next week.
So next 7 business days
Yeah $400 million ish ….
After we get news of IDE submission.
If and when approved, then that should more than double to $800 million+
Because you need to look at it from his perspective ….
Carnes didn’t make any money from the Tradition acquisition. He lost money from it, since APSI had to relinquish control of all of Tradition.
As a result, Carnes still has an “incentive” for his own self (not only just for shareholders) to still actively search for another merger or acquisition opportunity for APSI.
I never said I fully trusted Carnes ….
Whether he is at any or all fault for the Tradition situation is fair to speculate.
With that being said, there were still two positive things he did for the APSI ticker in the past. He spent his own money to clean up the shell and to also reduce the O/S from 50 million to 17 million shares. Those are facts that you or anyone else can’t deny.
An empty shell (especially a clean one) is worth at least $3 million market cap on average historically in the OTC. The current market cap of APSI now is only $400,000, which is only 1/8 the value of the historical average of an empty shell.
The news we got last night did say that APSI is still presently and actively looking for another trucking/logistics company.
There is still a very realistic chance that another company could come in this shell in the foreseeable future. Especially with it being cleaned up and only 17 million O/S. That right there makes it an attractive shell.
Looks like APSI is going back to being a clean shell.
No more Tradition.
The only good thing to happen to APSI over the past couple of years is that Carnes did get the shell clean and was able to get the O/S down from 50 million shares to 17 million shares.
The current status is now a clean shell, and still 17 million O/S. APSI can now look for another opportunity for acquisition or reverse merger. The shell will still be attractive due to its low O/S of 17 million and being cleaned up previously.
Unfortunately no more Tradition, so hopefully a new company comes in later this year or so, or at least within the next 6-12 months.
Gap at $0.03 still needs to be filled ….
LOL
Love this post from the other board today ….
RDGL BULLISH. The best is yet to come folks. We are waking up to a world where a treatment like RadioGel will soon be available to fight and kill cancer in humans… think about that and how much that’s worth
And ticker is getting changed soon.
We could see as high as $700 million in IDE submission ….
And far above $1.5 billion on approval.
It’s possible.
We could easily get that kind of buying pressure on these key milestones/catalysts.
Sounds like mid to late June ….
For when they’ll be submitting IDE, for approval.
At least the RSI has cooled off some, lol